Annals of Oncology 1:409-414, 1990
© 1990 European Society for Medical Oncology
review-article |
Review: 5-Fluorouracil cardiotoxicity: A critical review
Department of Medicine, Section of Hematology-Oncology, Pritzker School of Medicine, University of Chicago Chicago, USA
Correspondence to: William J. Gradishar, M.D. Department of Medicine, Section of Hematology-Oncology Northwestern University School of Medicine 233 E. Erie, Suite 700 Chicago, IL 60611, USA
5-Fluorouracil is a commonly administered chemotherapy agent that has infrequently been associated with cardiotoxicity. This review highlights the clinical features of this syndrome as described in reports from the medical literature. Clinical and laboratory evidence supporting proposed underlying mechanisms are reviewed.
5-Fluorouracil, toxicity, angina, thrombosis, myocardial infarction, coronary spasm
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. T.H. Yeh, A. T. Tong, D. J. Lenihan, S. W. Yusuf, J. Swafford, C. Champion, J.-B. Durand, H. Gibbs, A. A. Zafarmand, and M. S. Ewer Cardiovascular Complications of Cancer Therapy: Diagnosis, Pathogenesis, and Management Circulation, June 29, 2004; 109(25): 3122 - 3131. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. D. Bucaloiu, S. Dubagunta, K. K Pachipala, N. Kamal, and F. Fata Small-Cell Cancers, and an Unusual Reaction to Chemotherapy: CASE 4. FLUOROURACIL-RELATED SMALL BOWEL VASCULITIS J. Clin. Oncol., June 15, 2003; 21(12): 2442 - 2443. [Full Text] [PDF] |
||||

